Recruiting PHASE2 Essential Tremor

New treatment option for Essential Tremor

Official title Stereotactic Radiosurgery in the Treatment of Essential Tremor

ClinicalTrials.gov ID: NCT06821906

What this study is testing

What it's testing
The goal of this interventional study is to evaluate the effectiveness of treatment using stereotactic radiosurgery in the treatment of essential tremor in adult patients
  • Phase 2: a mid-size study of how well it works
  • Time commitment: about 5 years

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 and older

You may be able to join if

  • Essential tremor diagnosed, Parkinson's disease and other causes of tremor excluded.
  • Insufficient tremor control despite the use of available pharmacotherapy methods.
  • Disqualification from the Deeply Brain Stimualtion procedure/lack of consent to perform it on the side qualified for Stereotactic Radiosurgery
  • Consent to participate in a clinical trial.

You likely can't join if

  • Age under 50
  • Pregnancy
  • Duration of the disease less than 5 years
  • Dementia, psychosis or other condition that prevents giving informed consent to participate in the study
  • Poor general condition, serious comorbidities
  • Structural changes in the basal ganglia or major atrophic changes
See the full eligibility criteria
Who can join
  • Essential tremor diagnosed, Parkinson's disease and other causes of tremor excluded.
  • Insufficient tremor control despite the use of available pharmacotherapy methods.
  • Disqualification from the Deeply Brain Stimualtion procedure/lack of consent to perform it on the side qualified for Stereotactic Radiosurgery
  • Consent to participate in a clinical trial.
What rules you out
  • Age under 50
  • Pregnancy
  • Duration of the disease less than 5 years
  • Dementia, psychosis or other condition that prevents giving informed consent to participate in the study
  • Poor general condition, serious comorbidities
  • Structural changes in the basal ganglia or major atrophic changes
  • Previous radiotherapy to the brain covering the potential treatment area
  • Medical contraindications to magnetic resonance imaging

The study team makes the final eligibility decision.

Where it's taking place

  • Gliwice, Poland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Gliwice, Poland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.